In Theratechnologies' Phase 3 program the primary pharmacodynamic effect of daily 2 mg Tesamorelin was a selective reduction of visceral adipose tissue
doi:10.1016/j.biopsych.2008.04.022, PMID: 18534556 Magalhes PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M (2011) N -acetylcysteine for major depressive episodes in bipolar disorder
GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper) is a naturally occurring copper peptide found in the human body
PMCID: PMC1511567
There is no published human safety or efficacy data, no reproductive- or developmental-toxicology research, no studies in hepatic or renal impairment, and no drug-interaction studies